Zantac and other ranitidine products have recently been associated with a contaminate that’s linked to various cancers, including testicular cancer. The contaminant is NDMA (N-Nitrosodimethylamine), and multiple national and international health organizations classify it as a possible carcinogen (cancer-causing agent).
In the Spring of 2019, a small online pharmacy, Valisure, identified NDMA across lots of Zantac and similar generic products. The company does routine testing of the drugs it sells to ensure safety for its customers, and the contaminate was discovered during said testing. Upon this finding, several large drugstore chains discontinued selling the ranitidine medications, and several manufacturers pulled their products. In April of 2020, the Food and Drug Administration (FDA) issued a product withdrawal that removed all such medications from the shelves. The serious nature of this action is indicative of the serious nature of the finding.
The Mayo Clinic shares that testicular cancer is rare but that it is the most common form of cancer for boys and men between the ages of 15 and 35. Fortunately, this cancer generally responds well to treatment. Symptoms of testicular cancer include:
If you’re a Zantac user who is now facing a testicular cancer diagnosis, it’s in your best interest to discuss the strength of your case with a dedicated drug injury attorney today.
2 years ago I was involved in a trucking accident involving a 14-wheeler truck that nearly disabled me for life. Steve fought to make sure that I received the most possible compensation for my injuries. I was about to take the insurance company’s lowball offer, but decided to call Steve first – it was the best decision I’ve made yet
NOAH TAFFELPersonal Injury Victim